These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 22385180)
21. Use of molecular simulation for mapping conformational CYP2E1 epitopes. Vidali M; Hidestrand M; Eliasson E; Mottaran E; Reale E; Rolla R; Occhino G; Albano E; Ingelman-Sundberg M J Biol Chem; 2004 Dec; 279(49):50949-55. PubMed ID: 15456790 [TBL] [Abstract][Full Text] [Related]
22. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5. Wiercinska P; Squires EJ Drug Metab Dispos; 2010 May; 38(5):857-62. PubMed ID: 20164110 [TBL] [Abstract][Full Text] [Related]
23. The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity. Cheung C; Yu AM; Ward JM; Krausz KW; Akiyama TE; Feigenbaum L; Gonzalez FJ Drug Metab Dispos; 2005 Mar; 33(3):449-57. PubMed ID: 15576447 [TBL] [Abstract][Full Text] [Related]
24. Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures. Hartman JH; Letzig LG; Roberts DW; James LP; Fifer EK; Miller GP Biochem Pharmacol; 2015 Oct; 97(3):341-9. PubMed ID: 26225832 [TBL] [Abstract][Full Text] [Related]
25. [Changes of CYP2E1 activity in diabetic rat model]. Li L; Zhang Y Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852 [TBL] [Abstract][Full Text] [Related]
26. Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone. Gong EC; Chea S; Balupuri A; Kang NS; Chin YW; Choi YH Molecules; 2018 Mar; 23(3):. PubMed ID: 29498658 [TBL] [Abstract][Full Text] [Related]
27. Negatively cooperative binding properties of human cytochrome P450 2E1 with monocyclic substrates. Ping J; Wang YJ; Wang JF; Li X; Li YX; Hao P Curr Drug Metab; 2012 Sep; 13(7):1024-31. PubMed ID: 22591346 [TBL] [Abstract][Full Text] [Related]
28. Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism. Lee AM; Joshi M; Yue J; Tyndale RF Eur J Pharmacol; 2006 Dec; 552(1-3):151-8. PubMed ID: 17049344 [TBL] [Abstract][Full Text] [Related]
29. CYP2E1 regulation by benzene and other small organic chemicals in rat liver and peripheral lymphocytes. González-Jasso E; López T; Lucas D; Berthou F; Manno M; Ortega A; Albores A Toxicol Lett; 2003 Sep; 144(1):55-67. PubMed ID: 12919724 [TBL] [Abstract][Full Text] [Related]
30. Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments. Lucas D; Ferrara R; Gonzales E; Albores A; Manno M; Berthou F Toxicol Lett; 2001 Oct; 124(1-3):71-81. PubMed ID: 11684359 [TBL] [Abstract][Full Text] [Related]
31. Phenotyping of cytochrome P450 2E1 in vitro and in vivo. Ernstgård L; Johanson G; Karlsson AS; Warholm M Curr Drug Metab; 2007 Jun; 8(5):493-8. PubMed ID: 17584020 [TBL] [Abstract][Full Text] [Related]
32. Mammalian PC-12 cell genetically engineered for human cytochrome P450 2E1 expression. Mapoles J; Berthou F; Alexander A; Simon F; Ménez JF Eur J Biochem; 1993 Jun; 214(3):735-45. PubMed ID: 8391436 [TBL] [Abstract][Full Text] [Related]
33. Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole. Stresser DM; Perloff ES; Mason AK; Blanchard AP; Dehal SS; Creegan TP; Singh R; Gangl ET Drug Metab Dispos; 2016 Aug; 44(8):1424-30. PubMed ID: 27149898 [TBL] [Abstract][Full Text] [Related]
34. Functional characterization of three human cytochrome p450 2E1 variants with amino acid substitutions. Hanioka N; Tanaka-Kagawa T; Miyata Y; Matsushima E; Makino Y; Ohno A; Yoda R; Jinno H; Ando M Xenobiotica; 2003 Jun; 33(6):575-86. PubMed ID: 12851035 [TBL] [Abstract][Full Text] [Related]
35. Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1. Kurata N; Nishimura Y; Iwase M; Fischer NE; Tang BK; Inaba T; Yasuhara H Xenobiotica; 1998 Nov; 28(11):1041-7. PubMed ID: 9879636 [TBL] [Abstract][Full Text] [Related]
36. CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling. Collom SL; Jamakhandi AP; Tackett AJ; Radominska-Pandya A; Miller GP Arch Biochem Biophys; 2007 Mar; 459(1):59-69. PubMed ID: 17222385 [TBL] [Abstract][Full Text] [Related]
37. A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome p450 2E1. Lewis DF; Sams C; Loizou GD J Biochem Mol Toxicol; 2003; 17(1):47-52. PubMed ID: 12616646 [TBL] [Abstract][Full Text] [Related]
38. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855 [TBL] [Abstract][Full Text] [Related]
39. Study of the fragmentation mechanism of protonated 6-hydroxychlorzoxazone: application in simultaneous analysis of CYP2E1 activity with major human cytochrome P450s. Anari MR; Bakhtiar R; Franklin RB; Pearson PG; Baillie TA Anal Chem; 2003 Feb; 75(3):469-78. PubMed ID: 12585472 [TBL] [Abstract][Full Text] [Related]
40. Type II ligands as chemical auxiliaries to favor enzymatic transformations by P450 2E1. Ménard A; Fabra C; Huang Y; Auclair K Chembiochem; 2012 Nov; 13(17):2527-36. PubMed ID: 23129539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]